Production (Stage)
Guardant Health, Inc.
GH
$38.00
$0.952.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.76% | 30.16% | 33.87% | 29.23% | 30.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.76% | 30.16% | 33.87% | 29.23% | 30.90% |
| Cost of Revenue | 14.44% | 24.12% | 29.29% | 34.49% | 23.03% |
| Gross Profit | 24.76% | 34.24% | 36.96% | 25.82% | 36.43% |
| SG&A Expenses | 26.75% | 34.51% | 39.83% | 8.71% | 2.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.15% | 21.95% | 20.33% | 8.23% | 2.01% |
| Operating Income | -11.04% | -10.83% | -3.23% | 15.92% | 25.73% |
| Income Before Tax | 17.20% | 41.21% | -25.83% | -41.81% | 14.04% |
| Income Tax Expenses | -28.40% | 232.35% | -93.88% | -73.19% | 68.75% |
| Earnings from Continuing Operations | 17.24% | 40.65% | -25.15% | -41.03% | 13.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.24% | 40.65% | -25.15% | -41.03% | 13.89% |
| EBIT | -11.04% | -10.83% | -3.23% | 15.92% | 25.73% |
| EBITDA | -12.90% | -12.37% | -4.01% | 17.46% | 28.18% |
| EPS Basic | 18.68% | 43.17% | -19.75% | -25.31% | 27.37% |
| Normalized Basic EPS | -4.06% | -9.48% | 0.39% | 6.93% | 45.94% |
| EPS Diluted | 18.68% | 43.17% | -19.75% | -25.31% | 27.37% |
| Normalized Diluted EPS | -4.06% | -9.48% | 0.39% | 6.93% | 45.94% |
| Average Basic Shares Outstanding | 1.77% | 4.43% | 4.51% | 12.53% | 18.55% |
| Average Diluted Shares Outstanding | 1.77% | 4.43% | 4.51% | 12.53% | 18.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |